- Home
- RGR vs RAPT Comparison
RGR vs RAPT Comparison
Compare RGR & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGR
- RAPT
- Stock Information
- Founded
- RGR 1949
- RAPT 2015
- Country
- RGR United States
- RAPT United States
- Employees
- RGR N/A
- RAPT N/A
- Industry
- RGR Ordnance And Accessories
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- RGR Industrials
- RAPT Health Care
- Exchange
- RGR Nasdaq
- RAPT Nasdaq
- Market Cap
- RGR 553.4M
- RAPT 498.4M
- IPO Year
- RGR N/A
- RAPT 2019
- Fundamental
- Price
- RGR $46.23
- RAPT $29.50
- Analyst Decision
- RGR
- RAPT Buy
- Analyst Count
- RGR 0
- RAPT 7
- Target Price
- RGR N/A
- RAPT $35.14
- AVG Volume (30 Days)
- RGR 289.4K
- RAPT 337.2K
- Earning Date
- RGR 10-29-2025
- RAPT 11-11-2025
- Dividend Yield
- RGR 1.51%
- RAPT N/A
- EPS Growth
- RGR N/A
- RAPT N/A
- EPS
- RGR 0.35
- RAPT N/A
- Revenue
- RGR $536,291,000.00
- RAPT N/A
- Revenue This Year
- RGR N/A
- RAPT N/A
- Revenue Next Year
- RGR $3.39
- RAPT N/A
- P/E Ratio
- RGR $133.95
- RAPT N/A
- Revenue Growth
- RGR 3.31
- RAPT N/A
- 52 Week Low
- RGR $31.64
- RAPT $5.67
- 52 Week High
- RGR $46.64
- RAPT $32.35
- Technical
- Relative Strength Index (RSI)
- RGR 84.78
- RAPT 80.82
- Support Level
- RGR $42.15
- RAPT $26.93
- Resistance Level
- RGR $45.33
- RAPT $30.93
- Average True Range (ATR)
- RGR 1.26
- RAPT 2.71
- MACD
- RGR 0.25
- RAPT 0.23
- Stochastic Oscillator
- RGR 93.92
- RAPT 81.99
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.